Johnson & Johnson has made a bid to acquire all outstanding shares of Crucell N.V. for $2.3 billion in cash. J&J currently holds approximately 17.9% of Crucell’s total issued shares. The two companies entered negotiations in September 2010. Crucell’s management board and supervisory board unanimously supported the offer. The acceptance period for the offer begins on December 9th and, unless extended, ends on February 16, 2011. J&J expects to maintain Crucell’s exis...